Alicia Santos-Aledo, Adrian Plaza-Pegueroles, Marta Sanz-Murillo, Federico M. Ruiz, Jun Xu, David Gil-Carton, Dong Wang, Carlos Fernandez-Tornero
{"title":"低温电子显微镜揭示了 RNA 聚合酶 I 在缺失 DNA 病变处暂停和停滞的顺序机制","authors":"Alicia Santos-Aledo, Adrian Plaza-Pegueroles, Marta Sanz-Murillo, Federico M. Ruiz, Jun Xu, David Gil-Carton, Dong Wang, Carlos Fernandez-Tornero","doi":"10.1101/2024.09.09.611646","DOIUrl":null,"url":null,"abstract":"RNA polymerase I (Pol I) transcribes ribosomal DNA (rDNA) to produce the rRNA precursor, which accounts for up to 60% of the total transcriptional activity in growing cells. Pol I monitors rDNA integrity and influences cell survival, but little is known about how this enzyme processes abasic DNA lesions. Here, we report electron cryo-microscopy (cryo-EM) structures of Pol I at different stages of stalling at abasic sites, supported by in vitro transcription studies. Our results show that templating abasic sites slow nucleotide, which occurs by addition by base sandwiching between the RNA 3-prime end and the Pol I bridge helix. However, the presence of a templating abasic site induces opening of the Pol I cleft for either enzyme dissociation from DNA or for access of A12-Ct into the active site to stimulate RNA cleavage. Nucleotide addition opposite the lesion induces an early translocation intermediate that is different from previously-described RNA polymerase paused states, as DNA bases in the hybrid tilt to form hydrogen bonds with the newly-added RNA base. While in this state nucleotide addition is strongly disfavoured, intrinsic Pol I RNA cleavage activity acts as a failsafe route to minimize lesion bypass. Our results uncover a two-step mechanism leading to persistent Pol I stalling after nucleotide addition opposite Ap sites, which is distinct from arrest by CPD lesions and from Pol II blockage at Ap sites.","PeriodicalId":501108,"journal":{"name":"bioRxiv - Molecular Biology","volume":"98 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cryo-EM uncovers a sequential mechanism for RNA polymerase I pausing and stalling at abasic DNA lesions\",\"authors\":\"Alicia Santos-Aledo, Adrian Plaza-Pegueroles, Marta Sanz-Murillo, Federico M. Ruiz, Jun Xu, David Gil-Carton, Dong Wang, Carlos Fernandez-Tornero\",\"doi\":\"10.1101/2024.09.09.611646\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"RNA polymerase I (Pol I) transcribes ribosomal DNA (rDNA) to produce the rRNA precursor, which accounts for up to 60% of the total transcriptional activity in growing cells. Pol I monitors rDNA integrity and influences cell survival, but little is known about how this enzyme processes abasic DNA lesions. Here, we report electron cryo-microscopy (cryo-EM) structures of Pol I at different stages of stalling at abasic sites, supported by in vitro transcription studies. Our results show that templating abasic sites slow nucleotide, which occurs by addition by base sandwiching between the RNA 3-prime end and the Pol I bridge helix. However, the presence of a templating abasic site induces opening of the Pol I cleft for either enzyme dissociation from DNA or for access of A12-Ct into the active site to stimulate RNA cleavage. Nucleotide addition opposite the lesion induces an early translocation intermediate that is different from previously-described RNA polymerase paused states, as DNA bases in the hybrid tilt to form hydrogen bonds with the newly-added RNA base. While in this state nucleotide addition is strongly disfavoured, intrinsic Pol I RNA cleavage activity acts as a failsafe route to minimize lesion bypass. Our results uncover a two-step mechanism leading to persistent Pol I stalling after nucleotide addition opposite Ap sites, which is distinct from arrest by CPD lesions and from Pol II blockage at Ap sites.\",\"PeriodicalId\":501108,\"journal\":{\"name\":\"bioRxiv - Molecular Biology\",\"volume\":\"98 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"bioRxiv - Molecular Biology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1101/2024.09.09.611646\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"bioRxiv - Molecular Biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.09.09.611646","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
RNA 聚合酶 I(Pol I)转录核糖体 DNA(rDNA)以产生 rRNA 前体,它占生长细胞总转录活性的 60%。Pol I 监控着 rDNA 的完整性并影响着细胞的存活,但人们对这种酶如何处理消融 DNA 病变却知之甚少。在此,我们报告了 Pol I 在消减位点停滞的不同阶段的电子低温显微镜(cryo-EM)结构,并辅以体外转录研究。我们的研究结果表明,模板化消融位点会减慢核苷酸的速度,这是由 RNA 3-prime末端和Pol I桥螺旋之间的碱基夹层加成的。然而,模板化消融位点的存在会促使 Pol I 裂隙打开,使酶从 DNA 中解离,或使 A12-Ct 进入活性位点,从而刺激 RNA 的裂解。与病变相对的核苷酸添加会诱发早期易位中间体,这种中间体与之前描述的 RNA 聚合酶暂停状态不同,因为杂交体中的 DNA 碱基会倾斜,与新添加的 RNA 碱基形成氢键。在这种状态下,核苷酸的添加是极不受欢迎的,而固有的 Pol I RNA 裂解活性则充当了将病变旁路最小化的故障安全路径。我们的研究结果揭示了核苷酸添加到 Ap 位点对面后导致 Pol I 持续停滞的两步机制,这种停滞不同于 CPD 病变的停滞,也不同于 Pol II 在 Ap 位点的阻滞。
Cryo-EM uncovers a sequential mechanism for RNA polymerase I pausing and stalling at abasic DNA lesions
RNA polymerase I (Pol I) transcribes ribosomal DNA (rDNA) to produce the rRNA precursor, which accounts for up to 60% of the total transcriptional activity in growing cells. Pol I monitors rDNA integrity and influences cell survival, but little is known about how this enzyme processes abasic DNA lesions. Here, we report electron cryo-microscopy (cryo-EM) structures of Pol I at different stages of stalling at abasic sites, supported by in vitro transcription studies. Our results show that templating abasic sites slow nucleotide, which occurs by addition by base sandwiching between the RNA 3-prime end and the Pol I bridge helix. However, the presence of a templating abasic site induces opening of the Pol I cleft for either enzyme dissociation from DNA or for access of A12-Ct into the active site to stimulate RNA cleavage. Nucleotide addition opposite the lesion induces an early translocation intermediate that is different from previously-described RNA polymerase paused states, as DNA bases in the hybrid tilt to form hydrogen bonds with the newly-added RNA base. While in this state nucleotide addition is strongly disfavoured, intrinsic Pol I RNA cleavage activity acts as a failsafe route to minimize lesion bypass. Our results uncover a two-step mechanism leading to persistent Pol I stalling after nucleotide addition opposite Ap sites, which is distinct from arrest by CPD lesions and from Pol II blockage at Ap sites.